160 related articles for article (PubMed ID: 30526175)
41. Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.
Ahluwalia MS; Xie H; Dahiya S; Hashemi-Sadraei N; Schiff D; Fisher PG; Chamberlain MC; Pannullo S; Newton HB; Brewer C; Wood L; Prayson R; Elson P; Peereboom DM
J Neurooncol; 2015 Mar; 122(1):111-9. PubMed ID: 25534576
[TBL] [Abstract][Full Text] [Related]
42. Oligodendroglioma: pathology and molecular biology.
Engelhard HH; Stelea A; Cochran EJ
Surg Neurol; 2002 Aug; 58(2):111-7; discussion 117. PubMed ID: 12453646
[TBL] [Abstract][Full Text] [Related]
43. Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.
Katsetos CD; Del Valle L; Geddes JF; Aldape K; Boyd JC; Legido A; Khalili K; Perentes E; Mörk SJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):307-20. PubMed ID: 11939586
[TBL] [Abstract][Full Text] [Related]
44. Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion.
Pai T; Epari S; Desai S; Wadile A; Gupta T; Goda JS; Moiyadi A; Shetty P; Kane S; Jalali R
Neurol India; 2017; 65(1):113-120. PubMed ID: 28084254
[TBL] [Abstract][Full Text] [Related]
45. CyberKnife Radiosurgery for Extracranial Metastases of Oligodendroglioma: A Clinical Case Report.
Shaghaghian E; Park DJ; Yoo KH; Meola A; Chang SD
Cureus; 2023 Dec; 15(12):e51035. PubMed ID: 38264380
[TBL] [Abstract][Full Text] [Related]
46. [Diffuse bone marrow metastasis of an anaplastic oligodendroglioma].
Nakamura O; Watanabe T; Nomura K; Nakajima T
No Shinkei Geka; 1985 Aug; 13(8):903-9. PubMed ID: 4058667
[TBL] [Abstract][Full Text] [Related]
47. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours.
Kim JW; Park CK; Park SH; Kim YH; Han JH; Kim CY; Sohn CH; Chang KH; Jung HW
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):224-7. PubMed ID: 20587495
[TBL] [Abstract][Full Text] [Related]
48. Oligodendroglioma: pathology, molecular mechanisms and markers.
Wesseling P; van den Bent M; Perry A
Acta Neuropathol; 2015 Jun; 129(6):809-27. PubMed ID: 25943885
[TBL] [Abstract][Full Text] [Related]
49. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
50. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
Jentoft M; Giannini C; Rossi S; Mota R; Jenkins RB; Rodriguez FJ
Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
[TBL] [Abstract][Full Text] [Related]
51. Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
Acharya S; Robinson CG; Michalski JM; Mullen D; DeWees TA; Campian JL; Chundury A; Bottani B; Hallahan DE; Bradley JD; Huang J
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):334-343. PubMed ID: 29534896
[TBL] [Abstract][Full Text] [Related]
52. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
[TBL] [Abstract][Full Text] [Related]
53. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
[TBL] [Abstract][Full Text] [Related]
54. Sarcoma-like tumor originating from oligodendroglioma.
Shoji T; Saito R; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
Brain Tumor Pathol; 2016 Oct; 33(4):255-260. PubMed ID: 27333891
[TBL] [Abstract][Full Text] [Related]
55. Extraneural metastases of anaplastic oligodendroglioma.
Han SR; Yoon SW; Yee GT; Choi CY; Lee DJ; Sohn MJ; Chang SH; Whang CJ
J Clin Neurosci; 2008 Aug; 15(8):946-9. PubMed ID: 18280737
[TBL] [Abstract][Full Text] [Related]
56. Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion.
Hewer E; Beck J; Vassella E; Vajtai I
Neuropathology; 2014 Feb; 34(1):32-8. PubMed ID: 23711170
[TBL] [Abstract][Full Text] [Related]
57. Multimodal
Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
[TBL] [Abstract][Full Text] [Related]
58. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB
J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879
[TBL] [Abstract][Full Text] [Related]
59. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
60. [Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].
Malzkorn B; Reifenberger G
Pathologe; 2019 Mar; 40(2):131-139. PubMed ID: 30790013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
